New data published by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J.
Home »
Treating patients with advanced biliary tract cancers: Changing tactics
Medical research very rarely has a single end point. There is often no final answer, or silver bullet, the science
CRISPR study identifies gene that plays key role in metastasis of cancers to the lungs
A gene not previously linked to cancer has been shown to play a key role in the spread of certain
Study finds high tumor mutation burden predicts immunotherapy response in some, but not all, cancers
A high rate of genetic mutations within a tumor, known as high tumor mutation burden (TMB), was only useful for
Novel organoid models illuminate the path to cervical cancers
Organoids are increasingly being used in biomedical research. These are organ-like structures created in the laboratory that are only a
A step forward toward immunotherapy for hematological cancers
In cancer treatment, immunotherapy helps the patient’s immune system fight cancer, for example through better recognition of the cancer cells,
New model by CHOP researchers identifies noncoding mutations across five pediatric cancers
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new computational algorithm that has, for the first time, identified
Two immunotherapies merged into single, more effective treatment that may work against variety of cancers
Some of the most promising advances in cancer treatment have centered on immunotherapies that rev up a patient’s immune system
Moves and countermoves: How the immune system responds to lung cancer’s ‘tactics’
At its very core, cancer is a disease caused by DNA errors. Within tumour cell DNA, there are a multitude
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers
A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity